4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-043897
CEO and President bought 1,000 shares at $9.87 ($9,870)
From the SEC's structured data for this filing
Trades in this filing
Kendall Keith J · CEO and President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-27 | Purchase : show line 1 in the form | +1,000 | $9.87 | $9,870 | 621,139 | D |
| Open-market purchases · 1,000 sh · avg $9.87 · $9,870 | ||||||
Loading xslF345X03/form4.xml…